Filter results
You can narrow down the results using the filters
Topics
Our work
Diseases
11455 results
-
Literature review of international biosimilar medicines update – March to May 2018
This reports updates a literature review that looked at international and Australian clinical, academic and policy journals, as well as media articles or sources in relation to biosimilar medicines, to help inform policy development and communication activities. It covers March to May 2018. -
Private Health Insurance Reforms fact sheet: Agreement between the Government and the MTAA
This fact sheet explains the agreement between the Australian Government and the Medical Technology Association of Australia (MTAA). -
Imaging of nipple saving mastectomies
This clinical advice from the BreastScreen Australia (BSA) reviews the role of screening services for women who’ve had a nipple saving mastectomy. -
Tobacco plain packaging – placement of brand names
This guideline provides clear instructions on the placement of brand, business, company and variant names on cigarette packs and cartons. -
Review of Care Coordination within the Integrated Team Care (ITC) Program Summary report
This report investigates the impact of the ITC program on health outcomes for Aboriginal and Torres Strait Islander people with a chronic disease. -
Taskforce final report – Urology Clinical Committee
This report contains the Medicare Benefits Schedule (MBS) Review Taskforce's findings and recommendations to the Australian Government on its review of Urology MBS items. -
Australian Hearing – too important to privatise
Australian Government response to the Senate Select Committee on Health Third Interim Report: Australian Hearing – too important to privatise -
Procedure guidance for medicines funded through the Life Saving Drugs Program (LSDP)
This guidance document outlines our process and associated timelines to consider medicines seeking funding through the LSDP. It helps sponsors to prepare an application to make an ultra-rare disease medicine available on the LSDP. -
Evaluation of the Primary Health Networks Program
This 2018 evaluation of the Primary Health Networks assessed how the program had been implemented and whether it was meeting its goals. -
Ross River virus infection – Surveillance case definition
This document contains the surveillance case definition for Ross River virus infection, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
Smallpox – Surveillance case definition
This document contains the surveillance case definition for smallpox, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
Tuberculosis – Surveillance case definition
This document contains the surveillance case definition for tuberculosis, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
Tackling Indigenous Smoking program – Final evaluation report – July 2018
This report, completed in July 2018, evaluates how effective the Tackling Indigenous Smoking (TIS) program has been and whether it’s on target to achieve its long-term goals. -
Nudge vs Superbugs
A report into a behavioural economics trial to reduce the overprescribing of antibiotics. -
ATAGI clinical advice for immunisation providers regarding maternal vaccination through the NIP
This resource provides clinical advice from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding the use of vaccines for pregnant women. -
ATAGI advice to support changes to the National Immunisation Program from 1 July 2018
This resource provides clinical advice to support changes to the vaccines given at 12 and 18 months through the National Immunisation Program from 1 July 2018. -
Process for developing and reviewing PHLN’s laboratory case definitions
This document contains the process for developing and reviewing the Public Health Laboratory Network (PHLN) laboratory case definitions. -
National Cervical Screening Program – Quality Framework
Learn about how the National Cervical Screening Program is monitored to ensure it continues as a high-quality program and reduces illness and death from cervical cancer. -
BreastScreen Australia – Adverse events report (BSAADVEV)
BreastScreen Australia services and State Coordination Units (SCUs) use this form to report adverse events to the National Quality Management Committee (NQMC). -
Data considerations for the Australian Influenza Surveillance Report – 2018
This document outlines data considerations relevant to Australian Influenza Surveillance Reports (AISRs) from the 2018 and 219 influenza seasons. -
Taskforce findings – Diagnostic Imaging Clinical Committee Knee Imaging report
This document summarises the Medicare Benefits Schedule (MBS) Review Taskforce’s recommendations in response to the Diagnostic Imaging Clinical Committee's Knee Imaging report. -
Bone Marrow Transplant Program (BMTP) application for funding
The BMTP helps patients access international haemopoietic progenitor cell (HPC) donors for transplants. Use this form to apply for funding under the BMTP. -
enHealth guidance – The health effects of environmental noise
This guidance from the Environmental Health Standing Committee (enHealth) looked at the health impacts of environmental noise to support policy and regulation in Australia.research. -
Effectiveness of the Aged Care Quality Assessment and Accreditation Framework
Australian Government response to the Senate Community Affairs References Committee interim report: Effectiveness of the aged care quality assessment and accreditation framework -
MDAF communique – 14 June 2018
A summary of the major items discussed at the fourth MDAF meeting.